Latest Content

What Patients With Cancer Need to Know About Bladder Removal Surgery

August 1st 2025, 9:00pm

By Alex Biese

Article

CURE spoke with experts about radical cystectomy, or surgical removal of the bladder, for patients with bladder cancer.

Minimally Invasive Surgery Transforms Lung Cancer Recovery

August 1st 2025, 8:00pm

By Dr. Geoffrey B. Pelz

Video

Robotic and video-assisted thoracic surgery reduces recovery time for those with lung cancer, allowing some to leave the hospital the day after surgery.

BMT-CARE App Improves Quality of Life and Mental Health for Caregivers

August 1st 2025, 7:00pm

By Spencer Feldman

Article

BMT-CARE app boosted quality of life, lowered depression and PTSD symptoms, and improved coping mechanisms for caregivers of stem cell transplant patients.

Understanding Epithelioid Hemangioendothelioma: A Rare Vascular Cancer

August 1st 2025, 5:00pm

By Gina Mauro

Article

Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.

How Robotic Surgery Can Impact Outcomes For Those With Lung Cancer

August 1st 2025, 4:00pm

By Alex Biese

Article

CURE spoke with a thoracic surgeon about the impact of minimally invasive surgery for patients.

Oncolytic Virus Wins FDA Fast Track Designation in Soft Tissue Sarcoma

August 1st 2025, 2:59pm

By Ryan Scott

Article

The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue sarcoma.

The Significance of the Datroway FDA Approval in EGFR+ NSCLC

August 1st 2025, 1:00pm

By Dr. Jacob Sands

Video

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally advanced or metastatic EGFR+ NSCLC.

FDA Grants Orphan Drug Status to SAR446523 for Relapsed Myeloma

July 31st 2025, 9:00pm

By Spencer Feldman

Article

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for relapsed/refractory multiple myeloma.

What is a Neobladder? What Patients with Bladder Cancer Need to Know

July 31st 2025, 8:00pm

By Dr. Janet Kukreja

Video

Dr. Janet Kukreja explains one urinary diversion option available to patients undergoing bladder removal.

How Resilience Coaching May Help Young People With Advanced Cancer

July 31st 2025, 7:00pm

By Spencer Feldman

Article

A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life after 6 to 12 months.

July GU Cancer Highlights: Top 5 Updates Patients Should Know

July 31st 2025, 5:00pm

By Ryan Scott

Article

As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.

Can Journaling Help Heal After a Cancer Diagnosis?

July 31st 2025, 4:00pm

By Carla Deschamps

Article

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful recovery tool.

How GIST Differs From Other GI Cancers

July 31st 2025, 3:00pm

By Dr. Weijing Sun

Video

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.

How Can Self-Advocacy Improve Care for Newly Diagnosed Patients?

July 31st 2025, 1:00pm

By Staci Kirk

Video

Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.

Venclexta Treatment Combo is Being Reviewed by FDA For CLL

July 30th 2025, 9:00pm

By Ryan Scott

Article

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic lymphocytic leukemia.